Invenio Imaging Announces Clinical Research Collaboration Agreement

Invenio Imaging, Inc., a leader in intraoperative fresh tissue imaging and artificial intelligence, today announced that it has entered into a research collaboration agreement with the Lung Cancer Initiative at Johnson & Johnson* to develop and validate the NIO® Lung Cancer Reveal image analysis algorithm to assist physicians in the evaluation of bronchoscopic lung biopsies.

The NIO® Laser Imaging Systems allows rapid imaging of fresh tissue biopsies with subcellular resolution in the procedure room with minimal preparation while preserving the sample for additional downstream pathology analysis. “In this important clinical study, we will develop a novel image analysis algorithm based on machine learning to provide physicians with real-time feedback determining whether a biopsy sample contains cancer”, says Chris Freudiger, PhD, Co-Founder and CTO of Invenio Imaging.

“We are excited to undertake this ambitious clinical study in collaboration with the Lung Cancer Initiative”, says Jay Trautman, PhD, Co-Founder and CEO of Invenio Imaging.

NIO® Lung Cancer Reveal has not been cleared by the Food and Drug Administration for clinical use in the United States.

Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

"Our partnership with UCB highlights the potential of leveraging AI for improving care for many diseases, including osteoporosis" explains Richard Ljuhar, CEO at ImageBiopsy Lab.
Philips and Vanderbilt assessed 13 diagnostic imaging devices including MR, CT, ultrasound and X-ray, which account for an estimated 12,000 patient scans per month and found that, over a period of 10 years, they emit the CO₂ equivalent of approximately 1,000 gas cars driven for one year.
Advanced molecular imaging, magnetic resonance, computed tomography and digital radiography technologies from market leader United Imaging Healthcare are breaking new ground in medicine and helping to improve the quality of patient care around the world.
According to Stephen K. Hu, LG Business Solutions USA’s head of medical displays, RSNA attendees who visit LG’s booth #1361 can see how its wide variety of medical displays increase flexibility and choice while delivering leading performance and capabilities for various medical settings.
Apollo eBook introduces a paradigm shift in enterprise imaging, explaining how a multidisciplinary, patient-centric approach ensures improved patient outcomes, thinking beyond the radiology workflow to reflect both the workflows of other specialties and medical encounters.

By using this website you agree to accept Medical Device News Magazine Privacy Policy